Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Solid Biosciences Inc SLDB

Healthcare Biotechnology Drug Manufacturers - Specialty & Generic
Solid Biosciences Inc. is a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases. The Company is focused on advancing a portfolio of gene therapy candidates including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, AVB-401 for the treatment of BAG3... see more

Recent & Breaking News (NDAQ:SLDB)

Efficacy and Safety Data from Solid Biosciences' Ongoing IGNITE DMD Phase I/II Clinical Trial to be Presented at the 2021 MDA Clinical & Scientific Conference

GlobeNewswire February 24, 2021

Solid Biosciences to Present at Upcoming Investor Conferences

GlobeNewswire February 17, 2021

Solid Biosciences to Present at 39th Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 6, 2021

Solid Biosciences Announces $90 Million Private Placement

GlobeNewswire December 11, 2020

Solid Biosciences Reports Third Quarter 2020 Financial Results and Provides Business Update

GlobeNewswire November 5, 2020

Solid Biosciences to Host Third Quarter 2020 Financial Results and Business Update Call on November 5, 2020

GlobeNewswire November 3, 2020

Ultragenyx and Solid Biosciences Announce Strategic Collaboration to Develop and Commercialize New Gene Therapies for Duchenne Muscular Dystrophy

GlobeNewswire October 23, 2020

Solid Biosciences to Participate in Virtual Fireside Chat at the Chardan 4th Annual Genetic Medicines Conference

GlobeNewswire October 2, 2020

Solid Biosciences Announces FDA Lifts Clinical Hold on IGNITE DMD Clinical Trial

GlobeNewswire October 1, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Solid Biosciences Inc. - SLDB

PR Newswire July 29, 2020

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Solid Biosciences Inc. (SLDB) Investigation

ACCESSWIRE IA July 28, 2020

Solid Biosciences Provides Update Regarding the IGNITE DMD Phase I/II Clinical Hold

GlobeNewswire July 24, 2020

Solid Biosciences Announces Appointment of Ian F. Smith as Chairman of the Board of Directors

GlobeNewswire June 18, 2020

Solid Biosciences to Hold Virtual Annual Meeting of Stockholders on June 16, 2020

GlobeNewswire May 22, 2020

Solid Biosciences Presents Data from Duchenne Muscular Dystrophy Gene Therapy Program at ASGCT 23rd Annual Meeting

GlobeNewswire May 14, 2020

Solid Biosciences Provides Update regarding SGT-001 Phase I/II Clinical Hold on IGNITE DMD

GlobeNewswire May 7, 2020

Solid Biosciences Announces Appointment of Ian F. Smith to its Board of Directors

GlobeNewswire April 16, 2020

Solid Biosciences Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update

GlobeNewswire March 12, 2020

Solid Biosciences Announces Organizational Changes to Prioritize Development of SGT-001

GlobeNewswire January 9, 2020

Solid Biosciences Provides Data Update from SGT-001 Development Program

GlobeNewswire December 18, 2019